Goodwin advised Blueprint Medicines (NASDAQ: BPMC), on its underwritten public offering of 4,259,259 shares of its common stock at a public offering price of $81.00 per…
Blueprint Medicines’ $325.5 million Common Stock Offering
Goodwin advised Blueprint Medicines (NASDAQ: BPMC), on its underwritten public offering of 4,259,259 shares of its common stock at a public offering price of $81.00 per…